These peptides work through entirely different biological pathways, and understanding those differences is the key to optimizing your protocol
[1] Retatrutide: What the Evidence Actually Shows Retatrutides pivotal obesity dataset is a Phase 2, double-blind, randomised, placebo-controlled trial in adults with obesity (or overweight plus a weight-related condition), testing once-weekly doses up to 12 mg over 48 weeks
Gently roll the vial between your palms until the powder is fully dissolved
Digestive enzymes: As the name suggests, these help you digest food, which reduces gas buildup (when food remains undigested, it ferments, which results in gas)
The growing demand and approvals for GLP-1's is essentially a sign that access and use will become inevitable and I'd speak to that separately
In the future, functional studies regarding certain metabolites should be conducted in vitro and in EAE models to provide stronger evidence that altered metabolic pathways coordinate the immune system to maintain the immunoinflammatory state of MS
